SATELLOS ANNOUNCES COMPLETION OF ENROLLMENT IN BASECAMP PHASE 2 CLINICAL TRIAL OF FORAZAPADIN FOR DUCHENNE MUSCULAR DYSTROPHY

Reuters · 3d ago

Please log in to view news